Evidence map›Paper›PMID 30723320›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2019

Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome.

Thomas Besnard, Natacha Sloboda, Alice Goldenberg, Sébastien Küry, Benjamin Cogné, Flora Breheret, Eva Trochu, Solène Conrad, Marie Vincent, Wallid Deb and 29 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 57 citations in OpenAlex.

  1. Sterol biosynthesis, brain development, and disease.The Journal of clinical investigation · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 14 institutions in 4 countries.

Thomas BesnardCHU de Nantes, Service de Génétique Médicale, Nantes, France. thomas.besnard@chu-nantes.fr.
Natacha SlobodaINSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France.
Alice GoldenbergDepartment of Genetics, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
Sébastien KüryCHU de Nantes, Service de Génétique Médicale, Nantes, France.
Benjamin CognéCHU de Nantes, Service de Génétique Médicale, Nantes, France.
Flora BreheretCHU de Nantes, Service de Génétique Médicale, Nantes, France.
Eva TrochuCHU de Nantes, Service de Génétique Médicale, Nantes, France.
Solène ConradCHU de Nantes, Service de Génétique Médicale, Nantes, France.
Marie VincentCHU de Nantes, Service de Génétique Médicale, Nantes, France.
Wallid DebCHU de Nantes, Service de Génétique Médicale, Nantes, France.
Xavier BalguerieDepartment of Dermatology, University Hospital Center of Rouen, Rouen, France.
Sébastien BarbarotCHU de Nantes, Department of Dermatology, Nantes, France.
Geneviève BaujatDepartment of Medical Genetics, INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, IMAGINE Institute, Necker Enfants Malades Hospital, Paris, France.
Tawfeg Ben-OmranSection of Clinical and Metabolic Genetics, Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.
Anne-Claire BursztejnDermatology department, hôpital Brabois, Vandœuvre-Lès, Vandœuvre-lès-Nancy, France.
Virginie CarmignacCentre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
Alexandre N DattaDepartment of Pediatric Neurology and Developmental Medicine, University of Basel Children's Hospital (UKBB), Basel, Switzerland.
Aline DelignièresCH Auray-Vannes, Hôpital Bretagne Atlantique, Service de Pediatrie, Vannes, France.
Laurence FaivreCentre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
Betty GardieL'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
Jean-Louis GuéantINSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France.
Paul KuentzCentre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
Marion LengletL'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
Marie-Cécile NassognePediatric Neurology Unit, Cliniques Universitaires Saint-Luc, Universite Catholique de Louvain, Brussels, Belgium.
Vincent RamaekersCenter of Autism and Department of Genetics, University Hospital Liege (CHU), Liège, Belgium.
Rhonda E SchnurGeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
Yue SiGeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
Erin TortiGeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
Julien ThevenonCentre de Génétique, Hôpital Couple-Enfant, CHU de Grenoble-Alpes, La Tronche, France.
Pierre VabresCentre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
Lionel Van MaldergemCentre de génétique humaine, Université de Franche-Comté, Besançon, France.
Dorothea WandDepartment Medical Genetic and Pathology, University Hospital of Basel (USB), Basel, Switzerland.
Arnaud WiedemannINSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France.
Bertrand CariouL'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
Richard RedonL'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
Antonin LamazièreLaboratory of Mass Spectrometry, INSERM ERL 1157, CNRS UMR 7203 LBM, Sorbonne Universités-UPMC, CHU Saint-Antoine, Paris, France.
Stéphane BézieauCHU de Nantes, Service de Génétique Médicale, Nantes, France.
Francois FeilletINSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France.
Bertrand IsidorCHU de Nantes, Service de Génétique Médicale, Nantes, France. bertrand.isidor@chu-nantes.fr.
Centre National de la Recherche Scientifique · FRInserm · FRCentre Hospitalier Universitaire de Nantes · FRUniversité de Rouen Normandie · FRCentre hospitalier Bretagne Atlantique · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Liège · BECliniques Universitaires Saint-Luc · BEDélégation Paris 5 · FRHamad Medical Corporation · QAUniversité de franche-comté · FRUniversity Hospital of Basel · CHUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLanosterol synthase (LSS) gene was initially described in families with extensive congenital cataracts. Recently, a study has highlighted LSS associated with hypotrichosis simplex. We expanded the phenotypic spectrum of LSS to a recessive neuroectodermal syndrome formerly named alopecia with mental retardation (APMR) syndrome. It is a rare autosomal recessive condition characterized by hypotrichosis and intellectual disability (ID) or developmental delay (DD), frequently associated with early-onset epilepsy and other dermatological features.

methodsThrough a multicenter international collaborative study, we identified LSS pathogenic variants in APMR individuals either by exome sequencing or LSS Sanger sequencing. Splicing defects were assessed by transcript analysis and minigene assay.

resultsWe reported ten APMR individuals from six unrelated families with biallelic variants in LSS. We additionally identified one affected individual with a single rare variant in LSS and an allelic imbalance suggesting a second event. Among the identified variants, two were truncating, seven were missense, and two were splicing variants. Quantification of cholesterol and its precursors did not reveal noticeable imbalance.

conclusionIn the cholesterol biosynthesis pathway, lanosterol synthase leads to the cyclization of (S)-2,3-oxidosqualene into lanosterol. Our data suggest LSS as a major gene causing a rare recessive neuroectodermal syndrome.

Indexed as

Age of OnsetAlopeciaChildChild, PreschoolCholesterolDevelopmental DisabilitiesEpilepsyExome SequencingFemaleHumansInfantIntellectual DisabilityIntramolecular TransferasesLanosterolMaleMutationCholesterolIntramolecular TransferasesLanosterollanosterol synthaseoxidosqualeneSqualenealopeciacholesterol pathwayearly-onset epileptic encephalopathyintellectual disabilityLSS

Identifiers

PMID30723320
OpenAlexW2912869736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.